Literature DB >> 1958538

Androgen receptor abnormalities.

A O Brinkmann1, G G Kuiper, C Ris-Stalpers, H C van Rooij, G Romalo, M Trifiro, E Mulder, L Pinsky, H U Schweikert, J Trapman.   

Abstract

The human androgen receptor is a member of the superfamily of steroid hormone receptors. Proper functioning of this protein is a prerequisite for normal male sexual differentiation and development. The cloning of the human androgen receptor cDNA and the elucidation of the genomic organization of the corresponding gene has enabled us to study androgen receptors in subjects with the clinical manifestation of androgen insensitivity and in a human prostate carcinoma cell line (LNCaP). Using PCR amplification, subcloning and sequencing of exons 2-8, we identified a G----T mutation in the androgen receptor gene of a subject with the complete form of androgen insensitivity, which inactivates the splice donor site at the exon 4/intron 4 boundary. This mutation causes the activation of a cryptic splice donor site in exon 4, which results in the deletion of 41 amino acids from the steroid binding domain. In two other independently arising cases we identified two different nucleotide alterations in codon 686 (GAC; aspartic acid) located in exon 4. One mutation (G----C) results in an aspartic acid----histidine substitution (with negligible androgen binding), whereas the other mutation (G----A) leads to an aspartic acid----asparagine substitution (normal androgen binding, but a rapidly dissociating androgen receptor complex). Sequence analysis of the androgen receptor in human LNCaP-cells (lymph node carcinoma of the prostate) revealed a point mutation (A----G) in codon 868 in exon 8 resulting in the substitution of threonine by alanine. This mutation is the cause of the altered steroid binding specificity of the LNCaP-cell androgen receptor. The functional consequences of the observed mutations with respect to protein expression, specific ligand binding and transcriptional activation, were established after transient expression of the mutant receptors in COS and HeLa cells. These findings illustrate that functional errors in the human androgen receptor have an enormous impact on phenotype and fertility.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1958538     DOI: 10.1016/0960-0760(91)90201-f

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  7 in total

1.  Vitamin E succinate inhibits the function of androgen receptor and the expression of prostate-specific antigen in prostate cancer cells.

Authors:  Yu Zhang; Jing Ni; Edward M Messing; Eugene Chang; Chin-Rang Yang; Shuyuan Yeh
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

2.  Autophagy regulates lipolysis and cell survival through lipid droplet degradation in androgen-sensitive prostate cancer cells.

Authors:  Ramesh R Kaini; Laurel O Sillerud; Siqin Zhaorigetu; Chien-An A Hu
Journal:  Prostate       Date:  2012-01-31       Impact factor: 4.104

Review 3.  Molecular pathology of prostate cancer.

Authors:  C Hughes; A Murphy; C Martin; O Sheils; J O'Leary
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

4.  Androgen-induced proliferative quiescence in prostate cancer cells: the role of AS3 as its mediator.

Authors:  P Geck; M V Maffini; J Szelei; C Sonnenschein; A M Soto
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

Review 5.  Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.

Authors:  A Valentino; P Reclusa; R Sirera; M Giallombardo; C Camps; P Pauwels; S Crispi; C Rolfo
Journal:  Clin Transl Oncol       Date:  2017-01-04       Impact factor: 3.405

Review 6.  Androgen signal transduction and prostatic carcinoma.

Authors:  H Klocker; Z Culig; F Kaspar; A Hobisch; J Eberle; A Reissigl; G Bartsch
Journal:  World J Urol       Date:  1994       Impact factor: 4.226

7.  Inhibition on JNK Mimics Silencing of Wnt-11 Mediated Cellular Response in Androgen-Independent Prostate Cancer Cells.

Authors:  Elif Damla Arisan; Ozge Rencuzogullari; Buse Keskin; Guy H Grant; Pinar Uysal-Onganer
Journal:  Biology (Basel)       Date:  2020-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.